The interview is part of the Spain Healthcare & Life Sciences Review 2022 PharmaBoardroom will soon be publishing.

In the interview, Gurutz talks about the creation of VIVEbiotech, its activity and specialization in viral vectors, its expertise not only in production but also in virology, and about the future of advanced therapies in general, and in our territory, in particular.

Many thanks to PharmaBoardroom for echoing the activity of VIVEbiotech!

You can read the full article here.